$JCTC
JEWETT CAMERON TRADING CO LTD

2024 Q1 Form 10-Q Financial Statement

#000107997324000069 Filed on January 16, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4
Revenue $8.229M $9.806M
YoY Change 1.05% -22.04%
Cost Of Revenue $6.165M $7.850M
YoY Change -0.94% -19.22%
Gross Profit $2.065M $1.956M
YoY Change 7.5% -31.6%
Gross Profit Margin 25.09% 19.95%
Selling, General & Admin $2.700M $948.5K
YoY Change 146.34% 14.72%
% of Gross Profit 130.79% 48.49%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $91.04K $97.90K
YoY Change 3.36% -12.23%
% of Gross Profit 4.41% 5.0%
Operating Expenses $2.791M $2.745M
YoY Change -10.84% -4.23%
Operating Profit -$726.7K -$789.2K
YoY Change -39.95% 11509.65%
Interest Expense $19.82K $6.855K
YoY Change -82.69% -92.08%
% of Operating Profit
Other Income/Expense, Net $0.00 $2.533M
YoY Change -100.0% -3026.33%
Pretax Income -$707.4K $1.744M
YoY Change -46.59% -1967.78%
Income Tax -$173.3K $452.0K
% Of Pretax Income 25.93%
Net Earnings -$534.2K $1.292M
YoY Change -45.05% -1851.0%
Net Earnings / Revenue -6.49% 13.17%
Basic Earnings Per Share -$0.15 $0.37
Diluted Earnings Per Share -$0.15 $0.37
COMMON SHARES
Basic Shares Outstanding 3.505M shares 3.499M shares
Diluted Shares Outstanding 3.504M shares 3.499M shares

Balance Sheet

Concept 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.149M $3.558M
YoY Change 328.23% 104.2%
Cash & Equivalents $1.149M $3.558M
Short-Term Investments
Other Short-Term Assets $796.4K $613.4K
YoY Change -20.58% -26.34%
Inventory $17.58M $17.51M
Prepaid Expenses $796.4K $613.4K
Receivables $4.676M $3.365M
Other Receivables $0.00 $0.00
Total Short-Term Assets $24.20M $25.05M
YoY Change -15.42% -15.98%
LONG-TERM ASSETS
Property, Plant & Equipment $4.451M $4.546M
YoY Change -9.74% -4.37%
Goodwill
YoY Change
Intangibles $112.6K $112.8K
YoY Change 243.18% 241.03%
Long-Term Investments
YoY Change
Other Assets $226.2K $229.1K
YoY Change -43.18% 409.02%
Total Long-Term Assets $4.790M $4.888M
YoY Change -10.67% 1.16%
TOTAL ASSETS
Total Short-Term Assets $24.20M $25.05M
Total Long-Term Assets $4.790M $4.888M
Total Assets $28.99M $29.94M
YoY Change -14.67% -13.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.190M $2.803M
YoY Change 208.38% 102.95%
Accrued Expenses $1.739M $1.397M
YoY Change 2.8% -13.86%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.102M $4.549M
YoY Change -62.38% -57.09%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.102M $4.549M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $4.102M $4.549M
YoY Change -62.38% -57.09%
SHAREHOLDERS EQUITY
Retained Earnings $23.26M $23.80M
YoY Change 8.3% 5.99%
Common Stock $826.9K $825.5K
YoY Change 0.17% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $24.89M $25.39M
YoY Change
Total Liabilities & Shareholders Equity $28.99M $29.94M
YoY Change -14.67% -13.59%

Cashflow Statement

Concept 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$534.2K $1.292M
YoY Change -45.05% -1851.0%
Depreciation, Depletion And Amortization $91.04K $97.90K
YoY Change 3.36% -12.23%
Cash From Operating Activities -$2.412M $4.632M
YoY Change 14.4% 567.21%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $3.500K $101.7K
YoY Change
Cash From Investing Activities $3.500K $101.7K
YoY Change -101.32% -380.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -$1.259M
YoY Change -100.0% -309.88%
NET CHANGE
Cash From Operating Activities -2.412M $4.632M
Cash From Investing Activities 3.500K $101.7K
Cash From Financing Activities 0.000 -$1.259M
Net Change In Cash -2.409M $3.474M
YoY Change 63.41% 176.19%
FREE CASH FLOW
Cash From Operating Activities -$2.412M $4.632M
Capital Expenditures
Free Cash Flow $4.632M
YoY Change 603.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 dei Amendment Flag
AmendmentFlag
false
CY2023Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--08-31
CY2023Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q4 dei Entity Central Index Key
EntityCentralIndexKey
0000885307
CY2023Q4 us-gaap Notes Payable
NotesPayable
usd
CY2022Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
CY2022Q4 us-gaap Other Income
OtherIncome
usd
CY2023Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
usd
CY2023Q4 jctcf Increase Decrease In Prepaid Income Taxes
IncreaseDecreaseInPrepaidIncomeTaxes
usd
CY2022Q4 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
usd
CY2022Q4 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
usd
CY2023Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2023Q4 us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
shares
CY2022Q4 us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
shares
CY2023Q4 jctcf Agricultural Seed Products
AgriculturalSeedProducts
usd
CY2022Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q4 dei Document Type
DocumentType
10-Q
CY2023Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q4 dei Document Period End Date
DocumentPeriodEndDate
2023-11-30
CY2023Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q4 dei Entity File Number
EntityFileNumber
000-19954
CY2023Q4 dei Entity Registrant Name
EntityRegistrantName
JEWETT-CAMERON TRADING COMPANY LTD
CY2023Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
A1
CY2023Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
CY2023Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
32275 N.W. Hillcrest
CY2023Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
North Plains
CY2023Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
OR
CY2023Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
97133
CY2023Q4 dei City Area Code
CityAreaCode
(503)
CY2023Q4 dei Local Phone Number
LocalPhoneNumber
647-0110
CY2023Q4 dei Security12b Title
Security12bTitle
Common Stock, no par value
CY2023Q4 dei Trading Symbol
TradingSymbol
JCTCF
CY2023Q4 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q4 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q4 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q4 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3504802 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3558168 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
83696 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3365430 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5634924 usd
CY2023Q4 us-gaap Inventory Net Of Allowances Customer Advances And Progress Billings
InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings
410325 usd
CY2023Q3 us-gaap Inventory Net Of Allowances Customer Advances And Progress Billings
InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings
497884 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
17513417 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
18339048 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
613358 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
630788 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
25050373 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
24688456 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4545687 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4655427 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
112847 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
134845 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
229062 usd
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
319875 usd
CY2023Q4 us-gaap Assets
Assets
29937969 usd
CY2023Q3 us-gaap Assets
Assets
29798603 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2802837 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2181194 usd
CY2023Q3 us-gaap Notes Payable
NotesPayable
1259259 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
349745 usd
CY2023Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
147629 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1396519 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2113194 usd
CY2023Q4 us-gaap Liabilities
Liabilities
4549101 usd
CY2023Q3 us-gaap Liabilities
Liabilities
5701276 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
21567564 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
21567564 shares
CY2023Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2023Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3498899 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3498899 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
825468 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
825468 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
765055 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
765055 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
23798345 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
22506804 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
25388868 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
24097327 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29937969 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29798603 usd
CY2023Q4 us-gaap Revenues
Revenues
9805841 usd
CY2022Q4 us-gaap Revenues
Revenues
12577500 usd
CY2023Q4 us-gaap Cost Of Revenue
CostOfRevenue
7849760 usd
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
9717800 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
1956081 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
2859700 usd
CY2023Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
948481 usd
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
826807 usd
CY2023Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
97903 usd
CY2022Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
111536 usd
CY2023Q4 us-gaap Salaries And Wages
SalariesAndWages
1698920 usd
CY2022Q4 us-gaap Salaries And Wages
SalariesAndWages
1928155 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
2745305 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
2866498 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-789224 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-6798 usd
CY2023Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
89655 usd
CY2023Q4 us-gaap Other Income
OtherIncome
2450000 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
6855 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
86552 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2532800 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-86552 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
1743576 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-93350 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
452035 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-19590 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
1291541 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-73760 usd
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.37
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3498899 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3496202 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3498899 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3496202 shares
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
24094650 usd
CY2022Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
23303 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-73760 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
24044193 usd
us-gaap Profit Loss
ProfitLoss
53134 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
24097327 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
1291541 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
25388868 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
1291541 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-73760 usd
CY2023Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
97903 usd
CY2022Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
111536 usd
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-23303 usd
CY2023Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
89655 usd
CY2023Q4 jctcf Writedown Of Intangible Assets
WritedownOfIntangibleAssets
21790 usd
CY2023Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
90813 usd
CY2022Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-20002 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2269494 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1954249 usd
CY2023Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-825631 usd
CY2022Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1370146 usd
CY2023Q4 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-17430 usd
CY2022Q4 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-488461 usd
CY2022Q4 jctcf Increase Decrease In Prepaid Income Taxes
IncreaseDecreaseInPrepaidIncomeTaxes
-412 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-95032 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-419811 usd
CY2023Q4 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
202116 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4632031 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
694242 usd
CY2023Q4 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
101700 usd
CY2022Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36223 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
101700 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36223 usd
CY2023Q4 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
-1259259 usd
CY2022Q4 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
600000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1259259 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
600000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3474472 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1258019 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
83696 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
484463 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3558168 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1742482 usd
CY2023Q4 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_841_eus-gaap--UseOfEstimates_zqnQKEqaxnQe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><b><span id="xdx_86F_zkjOnXj0jdq">Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify">The preparation of consolidated financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates incorporated into the Company’s consolidated financial statements include the estimated useful lives for depreciable and amortizable assets, the estimated allowances for doubtful accounts receivable and inventory obsolescence, possible product liability and possible product returns, and litigation contingencies and claims. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"></p>
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3558168 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
83696 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
18339048 usd
CY2023Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
29937969 usd
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
34646468 usd
CY2023Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
97903 usd
CY2022Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
111536 usd
CY2023Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1291541 usd
CY2022Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-73760 usd
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3498899 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3496202 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3498899 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3496202 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3558168 usd
CY2023Q4 jctcf Pet Fencing And Other Products
PetFencingAndOtherProducts
16878064 usd
CY2023Q3 jctcf Pet Fencing And Other Products
PetFencingAndOtherProducts
17741254 usd
CY2023Q4 jctcf Industrial Wood Products
IndustrialWoodProducts
635353 usd
CY2023Q3 jctcf Industrial Wood Products
IndustrialWoodProducts
584989 usd
CY2023Q3 jctcf Agricultural Seed Products
AgriculturalSeedProducts
12805 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
17513417 usd
CY2023Q4 jctcf Office Equipment
OfficeEquipment
668260 usd
CY2023Q3 jctcf Office Equipment
OfficeEquipment
668260 usd
CY2023Q4 jctcf Warehouse Equipment
WarehouseEquipment
1390774 usd
CY2023Q3 jctcf Warehouse Equipment
WarehouseEquipment
1556424 usd
CY2023Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
6209162 usd
CY2023Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
6209162 usd
CY2023Q4 us-gaap Land
Land
559065 usd
CY2023Q3 us-gaap Land
Land
559065 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8827261 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8992911 usd
CY2023Q4 jctcf Accumulated Depreciation Property Plant And Equipment
AccumulatedDepreciationPropertyPlantAndEquipment
-4281574 usd
CY2023Q3 jctcf Accumulated Depreciation Property Plant And Equipment
AccumulatedDepreciationPropertyPlantAndEquipment
-4337484 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4545687 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4655427 usd
CY2023Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
131405 usd
CY2023Q3 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
153195 usd
CY2023Q4 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
18558 usd
CY2023Q3 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
18350 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
112847 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
134845 usd
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
229062 usd
CY2023Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
319875 usd
CY2023Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
10000000 usd
CY2023Q4 us-gaap Line Of Credit Facility Maximum Monthend Outstanding Amount
LineOfCreditFacilityMaximumMonthendOutstandingAmount
0 usd
CY2022 us-gaap Line Of Credit Facility Maximum Monthend Outstanding Amount
LineOfCreditFacilityMaximumMonthendOutstandingAmount
1259259 usd
CY2023Q4 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0690 pure
CY2023Q4 us-gaap Pension Contributions
PensionContributions
96470 usd
CY2022Q4 us-gaap Pension Contributions
PensionContributions
126938 usd
CY2023Q4 us-gaap Revenues
Revenues
9805841 usd
CY2022Q4 us-gaap Revenues
Revenues
12577500 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
1743576 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-93350 usd
CY2023Q4 jctcf Sales
Sales
6125113 usd
CY2022Q4 jctcf Sales
Sales
7795215 usd
CY2023Q4 us-gaap Concentration Risk Customer
ConcentrationRiskCustomer
65%
CY2022Q4 us-gaap Concentration Risk Customer
ConcentrationRiskCustomer
56%
CY2023Q4 jctcf Concentration Volume Of Purchases
ConcentrationVolumeOfPurchases
4879797 usd
CY2022Q4 jctcf Concentration Volume Of Purchases
ConcentrationVolumeOfPurchases
6671072 usd
CY2023Q4 us-gaap Interest Paid Net
InterestPaidNet
29671 usd
CY2022Q4 us-gaap Interest Paid Net
InterestPaidNet
86552 usd
CY2023Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
173717 usd
CY2023Q3 us-gaap Legal Fees
LegalFees
2450000 usd

Files In Submission

Name View Source Status
jctcf-20231130_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
jctcf-20231130_pre.xml Edgar Link unprocessable
jctcf-20231130_cal.xml Edgar Link unprocessable
jctcf-20231130_lab.xml Edgar Link unprocessable
0001079973-24-000069-index-headers.html Edgar Link pending
0001079973-24-000069-index.html Edgar Link pending
0001079973-24-000069.txt Edgar Link pending
0001079973-24-000069-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
jctcf-20231130.xsd Edgar Link pending
jctcf_ex31x1.htm Edgar Link pending
jctcf_ex31x2.htm Edgar Link pending
jctcf_ex32x1.htm Edgar Link pending
jctcf_ex32x2.htm Edgar Link pending
jctc_10q-113023.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
jctc_10q-113023_htm.xml Edgar Link completed
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending